By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) 

10 Carlson Court
Suite 701
Etobicoke  Ontario  M9W 6L2  Canada
Phone: 416-679-0771 Fax: 416-679-0772


Company News
Trimel Pharmaceuticals (TRL.TO) Announces First Quarter 2015 Financial Results and Highlights 5/6/2015 12:24:45 PM
Trimel Pharmaceuticals (TRL.TO) To Present At The 2015 Bloom Burton & Co. Healthcare Investor Conference 4/13/2015 8:25:08 AM
Trimel Pharmaceuticals (TRL.TO) Announces Natesto Abstract Presentation At The 2015 Endocrine Society Annual Meeting 3/9/2015 12:00:40 PM
Trimel Pharmaceuticals (TRL.TO) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 3/5/2015 11:36:44 AM
Trimel Pharmaceuticals (TRL.TO) To Report Financial Results For 2014 And Host Conference Call To Update Investors 2/27/2015 10:57:16 AM
Trimel Pharmaceuticals (TRL.TO), Endo International (ENDP) Ink NATESTO Deal For Up To $195M 11/24/2014 5:46:23 AM
Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) (TRL.TO) Rises On FDA Approval For Natesto™ Nasal Gel 5/29/2014 7:24:20 AM
Struggling Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) (TRL.TO)'s Sexual Disorder Drug Tefina™ Delivers In Mid-Stage Study 5/28/2014 6:35:22 AM
Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) (TRL.TO) Announces Closing Of $10.5 Million Private Placement Of Common Shares 2/24/2014 7:38:38 AM
FDA Delays Trimel BioPharma's CompleoTRT™ PDUFA Date 1/17/2014 6:44:46 AM